<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Arak University</PublisherName>
				<JournalTitle>Cell and Tissue Journal</JournalTitle>
				<Issn>2228-7035</Issn>
				<Volume>9</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2018</Year>
					<Month>12</Month>
					<Day>22</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Evaluation of the protective effects of StachyslavandulifoliaVahl. on ethanol induced testicular damages in Wistarrats</ArticleTitle>
<VernacularTitle>Evaluation of the protective effects of StachyslavandulifoliaVahl. on ethanol induced testicular damages in Wistarrats</VernacularTitle>
			<FirstPage>321</FirstPage>
			<LastPage>332</LastPage>
			<ELocationID EIdType="pii">34429</ELocationID>
			
<ELocationID EIdType="doi">10.52547/JCT.9.4.321</ELocationID>
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>M</FirstName>
					<LastName>Mirzaei Fard</LastName>
<Affiliation>Department of bioscience, Malek Ashtar University of Tehran, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>A</FirstName>
					<LastName>Aramvash</LastName>
<Affiliation>Department of bioscience, Malek Ashtar University of Tehran, Tehran, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>02</Month>
					<Day>27</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Aim&lt;/strong&gt;: In this study, the effects of recombinant human growth hormone and Gemcitabine alone and in combination with each other were investigated on the lung fibroblast cell lines. &lt;br /&gt;&lt;strong&gt;Material and methods&lt;/strong&gt;: Human growth hormone at 10-400 ng/ml and Gemcitabine at 1-100 μg/ml concentrations were treated with the human lung fibroblast cells and the analysis were performed with MTT assay, propidium iodide staining and scratch assay. &lt;br /&gt;&lt;strong&gt;Results:&lt;/strong&gt; Studies of the cell cycle and MTT assay revealed the effect of growth hormone on the progression of the cell cycle and exit of G1 phase and the cell proliferation, and the inhibitory effects of the cell cycle and growth process by Gemcitabin compared with the control sample. The results of the scratch test indicated that the growth hormone at its effective concentrations caused increased the cell migration compared to control, while the Gemcitabin reduced the migration of the cell to the control. &lt;br /&gt;&lt;strong&gt;Conclusions:&lt;/strong&gt; Using growth hormone in combination to gemcitabin during chemotherapy treatment, it seems that we can reduce the rate of the neem normal cells death. Since these cells are more sensitive to growth hormone´s effect than cancer cells. &lt;br /&gt; </Abstract>
			<OtherAbstract Language="FA">&lt;strong&gt;Aim&lt;/strong&gt;: In this study, the effects of recombinant human growth hormone and Gemcitabine alone and in combination with each other were investigated on the lung fibroblast cell lines. &lt;br /&gt;&lt;strong&gt;Material and methods&lt;/strong&gt;: Human growth hormone at 10-400 ng/ml and Gemcitabine at 1-100 μg/ml concentrations were treated with the human lung fibroblast cells and the analysis were performed with MTT assay, propidium iodide staining and scratch assay. &lt;br /&gt;&lt;strong&gt;Results:&lt;/strong&gt; Studies of the cell cycle and MTT assay revealed the effect of growth hormone on the progression of the cell cycle and exit of G1 phase and the cell proliferation, and the inhibitory effects of the cell cycle and growth process by Gemcitabin compared with the control sample. The results of the scratch test indicated that the growth hormone at its effective concentrations caused increased the cell migration compared to control, while the Gemcitabin reduced the migration of the cell to the control. &lt;br /&gt;&lt;strong&gt;Conclusions:&lt;/strong&gt; Using growth hormone in combination to gemcitabin during chemotherapy treatment, it seems that we can reduce the rate of the neem normal cells death. Since these cells are more sensitive to growth hormone´s effect than cancer cells. &lt;br /&gt; </OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Proliferation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cell cycle</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Growth hormone</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Gemcitabine</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Human fibroblast</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jct.araku.ac.ir/article_34429_5824aa83d1ae73b56a67273714b57843.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
